Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.

Tsukumo Y, Alain T, Fonseca BD, Nadon R, Sonenberg N.

Nat Commun. 2016 Jun 20;7:11776. doi: 10.1038/ncomms11776.

2.

TFEB at a glance.

Napolitano G, Ballabio A.

J Cell Sci. 2016 Jul 1;129(13):2475-81. doi: 10.1242/jcs.146365. Epub 2016 Jun 1. Review.

PMID:
27252382
3.
4.

TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.

Argani P, Zhong M, Reuter VE, Fallon JT, Epstein JI, Netto GJ, Antonescu CR.

Am J Surg Pathol. 2016 Jun;40(6):723-37. doi: 10.1097/PAS.0000000000000631.

PMID:
26975036
5.

Primary alveolar soft part sarcoma of uterine corpus: a case report with immunohistochemical, ultrastructural study and review of literature.

Giordano G, D'Adda T, Varotti E, Crovini G, Silini EM.

World J Surg Oncol. 2016 Feb 2;14(1):24. doi: 10.1186/s12957-016-0780-1.

6.

Alveolar soft part sarcoma: Clinicopathological analysis and imaging results.

Qiao PF, Shen LH, Gao Y, Mi YC, Niu GM.

Oncol Lett. 2015 Nov;10(5):2777-2780. Epub 2015 Sep 10.

7.

Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes.

Mertens F, Antonescu CR, Mitelman F.

Genes Chromosomes Cancer. 2016 Apr;55(4):291-310. doi: 10.1002/gcc.22335. Epub 2015 Dec 18. Review.

8.

Alveolar soft part sarcoma presenting as a breast metastasis in a patient with a history of thyroid cancer: a case report.

Bychkov A, Sampatanukul P.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):9731-6. eCollection 2015.

9.

Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Pradhan D, Roy S, Quiroga-Garza G, Cieply K, Mahaffey AL, Bastacky S, Dhir R, Parwani AV.

Diagn Pathol. 2015 Sep 29;10:179. doi: 10.1186/s13000-015-0412-z.

11.
12.

Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines.

Goldberg JM, Fisher DE, Demetri GD, Neuberg D, Allsop SA, Fonseca C, Nakazaki Y, Nemer D, Raut CP, George S, Morgan JA, Wagner AJ, Freeman GJ, Ritz J, Lezcano C, Mihm M, Canning C, Hodi FS, Dranoff G.

Clin Cancer Res. 2015 Jul 15;21(14):3178-86. doi: 10.1158/1078-0432.CCR-14-2932. Epub 2015 Mar 24.

13.

Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications.

Agaram NP, Sung YS, Zhang L, Chen CL, Chen HW, Singer S, Dickson MA, Berger MF, Antonescu CR.

Am J Surg Pathol. 2015 Jun;39(6):813-25. doi: 10.1097/PAS.0000000000000389.

14.

Adult alveolar soft part sarcoma of the head and neck: a report of two cases and literature review.

Mullins BT, Hackman T.

Case Rep Oncol Med. 2014;2014:597291. doi: 10.1155/2014/597291. Epub 2014 Dec 23.

15.

Primary alveolar soft part sarcoma of the uterine cervix: a case report and literature review.

Feng M, Jiang W, He Y, Li L.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):8223-6. eCollection 2014. Review.

16.

TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis.

Schoolmeester JK, Dao LN, Sukov WR, Wang L, Park KJ, Murali R, Hameed MR, Soslow RA.

Am J Surg Pathol. 2015 Mar;39(3):394-404. doi: 10.1097/PAS.0000000000000349.

17.

Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment.

Goodwin ML, Jin H, Straessler K, Smith-Fry K, Zhu JF, Monument MJ, Grossmann A, Randall RL, Capecchi MR, Jones KB.

Cancer Cell. 2014 Dec 8;26(6):851-62. doi: 10.1016/j.ccell.2014.10.003. Epub 2014 Nov 26.

18.

Alveolar soft part sarcoma of the uterine cervix: a case report and review of the literature.

Lee HJ.

Korean J Pathol. 2014 Oct;48(5):361-5. doi: 10.4132/KoreanJPathol.2014.48.5.361. Epub 2014 Oct 27.

19.

Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: ultrastructural features and differential diagnosis.

Cykowski MD, Hicks J, Sandberg DI, Olar A, Bridge JA, Greipp PT, Navarro P, Kolodziej S, Bhattacharjee MB.

Ultrastruct Pathol. 2015 Feb;39(1):69-77. doi: 10.3109/01913123.2014.950778. Epub 2014 Sep 30.

20.

Human ASPL/TUG interacts with p97 and complements the proteasome mislocalization of a yeast ubx4 mutant, but not the ER-associated degradation defect.

Madsen L, Molbæk K, Larsen IB, Nielsen SV, Poulsen EG, Walmod PS, Hofmann K, Seeger M, Chien CY, Chen RH, Kriegenburg F, Hartmann-Petersen R.

BMC Cell Biol. 2014 Jul 31;15:31. doi: 10.1186/1471-2121-15-31.

Items per page

Supplemental Content

Write to the Help Desk